External Control Arms Overview
The page explains that an external control arm uses real-world data (RWD) to describe how a disease progresses in a population not receiving the experimental drug, which is especially useful for single-arm trials where a traditional control group is infeasible or unethical. It offers a downloadable case study illustrating how Datavant enables external control arms using an oncology example. The visible page content does not include the specific numerical details of that oncology case -- it functions mainly as an overview/gateway to the downloadable material.
The customer is anonymised in Datavant’s own case study — not withheld by us.
Datavant is the tokenization and linkage infrastructure behind most of the US real-world-data ecosystem — it de-identifies and connects patient records across health-data partners without exposing PII.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Datavant on its own site — read the original case study on datavant.com ↗
Related use cases
- 01Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment
- 02Profiling and Diagnosing Rare Disease Patients
- 03Case Study: The power of patient matching in real-world data
- 04Research Using Health Data Connected by Datavant
- 05Building a Trusted Partnership for Coding Excellence with Southwest General Health Center
- 06The Picture Comes into Focus for Patients Suffering with Rare Eye Disease